Usefulness of the Psoriatic Arthritis Screening and Evaluation Questionnaire to Monitor Disease Activity in Management of Patients with Psoriasis: Findings from the EPI-PSODE Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Psoriasis and psoriatic arthritis (PsA) are included in the group of immune-mediated inflammatory diseases (IMIDs) caused by systemic inflammation; however, indicators for monitoring inflammatory activity in patients with psoriasis, such as the Psoriasis Area and Severity Index (PASI), are limited. Objective: To determine whether the Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire can be used to monitor disease activity in patients with psoriasis. Methods: This was a multicenter, noninterventional, cross-sectional study. Demographic factors and PASI and PASE scores were collected to investigate associations between each. Results: PASE data were available for 1,255 patients, of whom 498 (39.7%) had a score of ≥37. Compared with the group with PASE score ＜37, the group with score ≥37 had a higher proportion of women (34.9% vs. 48.8%, p＜0.0001), older mean age at diagnosis (36.4 vs. 41.7 years, p＜0.0001), more severe disease activity using PASI and body surface area measures (p=0.0021 and p=0.0008, respectively), and higher mean body mass index (23.7 vs. 24.1, p=0.0411). In a multiple linear regression model, PASE score was positively associated with cutaneous disease activity (p＜0.0001). Conclusion: After risk-adjustment, PASE was positively associated with PASI, which suggests that PASE can be sensitive to disease activity. Since psoriasis is regarded as one of the IMIDs, PASE may be utilized as a tool not only to screen PsA but also to monitor disease activity.
Abstract
Background: Psoriasis and psoriatic arthritis (PsA) are included in the group of immune-mediated inflammatory diseases (IMIDs) caused by systemic inflammation; however, indicators for monitoring inflammatory activity in patients with psoriasis, such as the Psoriasis Area and Severity Index (PASI), are limited. Objective: To determine whether the Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire can be used to monitor disease activity in patients with psoriasis. Methods: This was a multicenter, noninterventional, cross-sectional study. Demographic factors and PASI and PASE scores were collected to investigate associations between each. Results: PASE data were available for 1,255 patients, of whom 498 (39.7%) had a score of ≥37. Compared with the group with PASE score ＜37, the group with score ≥37 had a higher proportion of women (34.9% vs. 48.8%, p＜0.0001), older mean age at diagnosis (36.4 vs. 41.7 years, p＜0.0001), more severe disease activity using PASI and body surface area measures (p=0.0021 and p=0.0008, respectively), and higher mean body mass index (23.7 vs. 24.1, p=0.0411). In a multiple linear regression model, PASE score was positively associated with cutaneous disease activity (p＜0.0001). Conclusion: After risk-adjustment, PASE was positively associated with PASI, which suggests that PASE can be sensitive to disease activity. Since psoriasis is regarded as one of the IMIDs, PASE may be utilized as a tool not only to screen PsA but also to monitor disease activity.
참고문헌 (39)
- Fitzpatrick TB, "Fitzpatrick’s dermatology in general medicine" (2012), McGraw-Hill Professional
- Gisondi P, "Cardiometabolic comorbidities and the approach to patients with psoriasis", Actas Dermosifiliogr, (100 Suppl 2), pp.14~21 (2009)
- Davidovici BB, "Psoriasis and systemic inflammatory diseases : potential mechanistic links between skin disease and co-morbid conditions", J Invest Dermatol, 130, pp.1785~1796 (2010)
- Ficco HM, "Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria", Clin Rheumatol, 33, pp.1489~1493 (2014)
- Catanoso M, "Epidemiology of psoriatic arthritis", Reumatismo, 64, pp.66~70 (2012)
- Gladman DD, "Psoriatic arthritis from Wright’s era until today", J Rheumatol Suppl, 83, pp.4~8 (2009)
- Ritchlin CT, "Psoriatic arthritis", N Engl J Med, 376, pp.957~970 (2017)
- Chin YY, "Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan : a nation-wide study", J Eur Acad Dermatol Venereol, 27, pp.1262~1268 (2013)
- Husni ME, "The PASE questionnaire : pilot-testing a psoriatic arthritis screening and evaluation tool", J Am Acad Dermatol, 57, pp.581~587 (2007)
- Alenius GM, "Inflammatory joint manifestations are prevalent in psoriasis : prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire", J Rheumatol, 29, pp.2577~2582 (2002)
- Ibrahim GH, "Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument : the Psoriasis Epidemiology Screening Tool(PEST)questionnaire", Clin Exp Rheumatol, 27, pp.469~474 (2009)
- Gladman DD, "Development and initial validation of a screening questionnaire for psoriatic arthritis : the Toronto Psoriatic Arthritis Screen(ToPAS)", Ann Rheum Dis, 68, pp.497~501 (2009)
- Tinazzi I, "The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis", Rheumatology(Oxford), 51, pp.2058~2063 (2012)
- 송해준, "The Clinical Profile of Patients with Psoriasis in Korea: A Nationwide Cross-Sectional Study (EPI-PSODE)", Annals of Dermatology, 29(4), pp.462~470 (2017), 대한피부과학회
- Ware JE Jr, "The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection", Med Care, 30, pp.473~483 (1992)
- Vernon MK, "Psychometric evaluation of the Medication Satisfaction Questionnaire(MSQ)to assess satisfaction with antipsychotic medication among schizophrenia patients", Schizophr Res, 118, pp.271~278 (2010)
- 유향석, "Screening for Psoriatic Arthritis in Korean Psoriasis Patients Using the Psoriatic Arthritis Screening Evaluation Questionnaire", Annals of Dermatology, 27(3), pp.265~268 (2015), 대한피부과학회
- Shin D, "Clinical features of psoriatic arthritis in Korean patients with psoriasis : a cross-sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires", Rheumatol Int, 36, pp.207~212 (2016)
- Dominguez PL, "Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire", Arch Dermatol Res, 301, pp.573~579 (2009)
- Baek HJ, "Spondylitis is the most common pattern of psoriatic arthritis in Korea", Rheumatol Int, 19, pp.89~94 (2000)
- 최효진, "한국인 건선관절염 환자의 임상양상 및 성별에 따른 비교", 대한내과학회지, 74(4), pp.418~425 (2008), 대한내과학회
- Oh EH, "Epidemiology and cardiovascular comorbidities in patients with psoriasis : a Korean nationwide population-based cohort study", J Dermatol, 44, pp.621~629 (2017)
- Ohara Y, "Prevalence and clinical characteristics of psoriatic arthritis in Japan", J Rheumatol, 42, pp.1439~1442 (2015)
- Haroon M, "High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires", Ann Rheum Dis, 72, pp.736~740 (2013)
- Dowlatshahi EA, "Markers of systemic inflammation in psoriasis : a systematic review and meta-analysis", Br J Dermatol, 169, pp.266~282 (2013)
- Sesso HD, "C-reactive protein and the risk of developing hypertension", JAMA, 290, pp.2945~2951 (2003)
- Armstrong AW, "The association between psoriasis and hypertension : a systematic review and meta-analysis of observational studies", J Hypertens, 31, pp.433~442 (2013)
- Solak Y, "Hypertension as an autoimmune and inflammatory disease", Hypertens Res, 39, pp.567~573 (2016)
- Husni ME, "Utility of the PASE questionnaire, psoriatic arthritis(PsA)prevalence and PsA improvement with anti-TNF therapy : results from the PRISTINE trial", J Dermatolog Treat, 25, pp.90~95 (2014)
- Eder L, "The incidence and risk factors for psoriatic arthritis in patients with psoriasis : a prospective cohort study", Arthritis Rheumatol, 68, pp.915~923 (2016)
- Gelfand JM, "Epidemiology of psoriatic arthritis in the population of the United States", J Am Acad Dermatol, 53, pp.573~ (2005)
- Langenbruch A, "Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis", Br J Dermatol, 171, pp.1123~1128 (2014)
- Wilson FC, "Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis : a population-based study", Arthritis Rheum, 61, pp.233~239 (2009)
- Love TJ, "Obesity and the risk of psoriatic arthritis : a population-based study", Ann Rheum Dis, 71, pp.1273~1277 (2012)
- Li W, "Obesity and risk of incident psoriatic arthritis in US women", Ann Rheum Dis, 71, pp.1267~1272 (2012)
- Thijssen E, "Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis", Rheumatology(Oxford), 54, pp.588~600 (2015)
- Ogdie A, "Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis : a review of available evidence", Curr Rheumatol Rep, 17, pp.64~ (2015)
- Tey HL, "Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis", J Dermatol, 37, pp.426~430 (2010)
- Kadir Berat Oyur, "Turkish PASE: Turkish Version of the Psoriatic Arthritis Screening and Evaluation Questionnaire", Annals of Dermatology, 26(4), pp.457~461 (2014), 대한피부과학회